Skip to main content

Arcturus Therapeutics Ltd(ARCT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics

PR Newswire - Mon Dec 12, 2022

CSL to access late-stage next-generation mRNA platform technology, enabling development of vaccines for COVID-19, influenza, multi-pathogen pandemic preparedness and other respiratory pathogens

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe